Heron Therapeutics
HRTX
#8293
Rank
$0.24 B
Marketcap
$1.32
Share price
-1.49%
Change (1 day)
-21.89%
Change (1 year)

Market capitalization of Heron Therapeutics (HRTX)

Market cap: $0.24 Billion USD

As of February 2026 Heron Therapeutics has a market cap of $0.24 Billion USD. This makes Heron Therapeutics the world's 8293th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Heron Therapeutics from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026$0.24 B3.13%
2025$0.23 B-0.44%
2024$0.23 B-7.6%
2023$0.25 B-14.16%
2022$0.29 B-68.06%
2021$0.93 B-51.84%
2020$1.93 B-8.93%
2019$2.12 B4.65%
2018$2.02 B74.56%
2017$1.16 B126.29%
2016$0.51 B-46.75%
2015$0.96 B227.88%
2014$0.29 B40.15%
2013$0.20 B27.36%
2012$0.16 B258.05%
2011$46 M153.99%
2010$18.11 M-64%
2009$50.31 M287.2%
2008$12.99 M-73.29%
2007$48.65 M39.6%
2006$34.85 M-9.9%
2005$38.67 M-6.36%
2004$41.3 M-18.32%
2003$50.57 M147.09%
2002$20.46 M-64.09%
2001$56.99 M18.78%
2000$47.98 M-30.62%
1999$69.16 M-35.63%
1998$0.10 B-16.67%
1997$0.12 B-7.89%
1996$0.13 B

End of Day market cap according to different sources

On Feb 1st, 2026 the market cap of Heron Therapeutics was reported to be:

$0.24 Billion USD
by Nasdaq info icon info icon
$0.24 Billion USD
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
SurModics
SRDX
$0.61 B 153.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Pacira Biosciences
PCRX
$0.88 B 265.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$3.78 B 1,462.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
$5.59 B 2,211.96%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Nektar Therapeutics
NKTR
$0.75 B 213.73%๐Ÿ‡บ๐Ÿ‡ธ USA